Wealthcare Advisory Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382K | Buy |
15,678
+590
| +4% | +$14.4K | 0.01% | 718 |
|
|
2025
Q1 | $313K | Sell |
15,088
-815
| -5% | -$16.9K | 0.01% | 730 |
|
|
2024
Q4 | $374K | Buy |
15,903
+435
| +3% | +$10.2K | 0.01% | 648 |
|
|
2024
Q3 | $396K | Sell |
15,468
-1,815
| -11% | -$46.5K | 0.01% | 630 |
|
|
2024
Q2 | $406K | Buy |
+17,283
| New | +$406K | 0.01% | 582 |
|
|
2022
Q2 | – | Sell |
-5,029
| Closed | -$231K | – | 566 |
|
|
2022
Q1 | $231K | Sell |
5,029
-1,005
| -17% | -$46.2K | 0.01% | 484 |
|
|
2021
Q4 | $370K | Sell |
6,034
-336
| -5% | -$20.6K | 0.02% | 389 |
|
|
2021
Q3 | $476K | Sell |
6,370
-1,306
| -17% | -$97.6K | 0.03% | 327 |
|
|
2021
Q2 | $710K | Sell |
7,676
-1,313
| -15% | -$121K | 0.05% | 246 |
|
|
2021
Q1 | $798K | Buy |
8,989
+2,560
| +40% | +$227K | 0.06% | 221 |
|
|
2020
Q4 | $600K | Buy |
+6,429
| New | +$600K | 0.05% | 209 |
|
|
2020
Q2 | – | Sell |
-759
| Closed | -$24K | – | 378 |
|
|
2020
Q1 | $24K | Buy |
+759
| New | +$24K | ﹤0.01% | 683 |
|